Global Neurology Clinical Trials Market Share

Market Share of Global Neurology Clinical Trials Industry

In the current scenario, the number of product launches, collaborations, and other strategies by the market players is increasing, and it's fueling the global neurology clinical trial market. The market is competitive in nature globally and fragmented due to the presence of several major players in the market. Supernus Pharmaceuticals, Inc. (Adamas Pharmaceuticals), AstraZeneca, Aurobindo Pharma, Eisai Co., Ltd., Eli Lilly and Company, Aurora Health Care, AbbVie Inc., Zydus Group, Athira Pharma, Inc., Annovis Bio, Biogen, GlaxoSmithKline plc, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., and Sanofi are some of the major players among others.

Neurology Clinical Trials Market Leaders

1. AbbVie Inc.

2. Biogen

3. Merck & Co., Inc.

4. Novartis AG

5. Sanofi

*Disclaimer: Major Players sorted in no particular order